Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Women who have quickly lost weight say strangers are now more likely to smile at them or strike up a conversation.

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...

Most aspiring med spa owners don’t realize that in many states, they legally can’t own their business without a medical ...

AN URGENT health warning has been issued to Scots over the dangers of getting fillers and weight loss jabs at boozy ‘Botox ...